- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on High-risk Smoldering Multiple Myeloma
Total 3950 results
-
University of New MexicoNational Institute of Mental Health (NIMH)CompletedPsychosis | Clinical High Risk for Psychosis | First Episode PsychosisUnited States
-
Heidelberg UniversityUnknownFocus: Immunocompromised Individuals at High Risk of Aqcuiring Invasive AspergillosisGermany
-
National Cancer Institute (NCI)Cancer and Leukemia Group BCompletedBreast Cancer | High Risk | Cyclophosphamide | Positive Nodes | DoxorubicinUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Multiple Myeloma-Light Chain OnlyUnited States
-
University of Illinois at ChicagoCompletedMultiple Myeloma, Relapsed | Multiple Myeloma, Refractory to Standard TreatmentUnited States
-
Shanghai Theorion Pharmaceutical Co Ltd.Shanghai Institute of Materia Medica, Chinese Academy of SciencesUnknownRefractory Multiple Myeloma | Recurrent Multiple MyelomaChina
-
OncotherapeuticsWithdrawnStage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Plasma Cell NeoplasmUnited States
-
Technische Universität DresdenCharite University, Berlin, GermanyCompletedHigh-risk Alcohol Consumption Pattern | Low-risk Alcohol Consumption PatternGermany
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedChronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | High Risk Myelodysplastic Syndrome | Acute Myeloid Leukemia With Multilineage Dysplasia | Blasts 20-30 Percent of Bone Marrow Nucleated Cells | Blasts 20-30 Percent of Peripheral Blood White Cells | IPSS Risk Category Intermediate-2United States
-
Nantes University HospitalNot yet recruiting
-
K36 Therapeutics, Inc.RecruitingMultiple Myeloma | Myeloma | Myeloma MultipleUnited States, France, Spain, Canada
-
AHS Cancer Control AlbertaTom Baker Cancer CentreRecruitingMyeloma | Myeloma MultipleCanada
-
Azienda Ospedaliera Universitaria SeneseJanssen-Cilag S.p.A.RecruitingMyeloma MultipleItaly
-
University Hospital, BordeauxRecruiting
-
Ivan S MoiseevTerminated
-
Chong Kun Dang PharmaceuticalUnknownMyeloma, MultipleKorea, Republic of
-
Memorial Sloan Kettering Cancer CenterRecruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapse Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedStage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Plasma Cell NeoplasmUnited States
-
Medical College of WisconsinWithdrawnRefractory Multiple Myeloma | Relapse Multiple Myeloma
-
National Cancer Institute (NCI)CompletedStage III Multiple Myeloma | Unspecified Adult Solid Tumor, Protocol Specific | Refractory Multiple MyelomaUnited States
-
University of WashingtonGeneral ElectricCompletedArterial Occlusive Diseases | Hypertension | Pregnancy | Pregnancy, High Risk | Evidence of Liver TransplantationUnited States
-
AbbVieGenentech, Inc.CompletedChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Acute Myeloid Leukemia (AML) | Multiple Myeloma (MM) | Non-Hodgkin Lymphoma (NHL)Japan
-
PETHEMA FoundationAdknoma Health ResearchRecruitingRelapsed Multiple MyelomaSpain
-
Cartesian TherapeuticsCompleted
-
Association for Training, Education, and Research...CompletedRelapsed Multiple MyelomaFrance
-
Washington University School of MedicineWithdrawnMultiple Myeloma | Myeloma-Multiple
-
Shanghai Jiao Tong University School of MedicineGuangzhou Psychiatric Hospital; Suzhou Psychiatric Hospital; Tianjin Anding Hospital and other collaboratorsRecruitingSchizophrenia; Psychosis | Clinical High Risk | First Episode PsychosisChina
-
AmgenCompletedHyperlipidemia or Mixed Dyslipidemia at High Risk for Cardiovascular EventsJapan
-
National Cancer Institute (NCI)Not yet recruitingMyelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory High Risk Myelodysplastic Syndrome
-
Gilead SciencesCompletedChronic Lymphocytic Leukemia (CLL) | Acute Myeloid Leukemia (AML) | Multiple Myeloma (MM) | Lymphoma, Non-Hodgkin (NHL)United States
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedRelapsed or Refractory Multiple Myeloma | Relapsed or Refractory Acute Myeloid Leukemia | Relapsed or Refractory Non-Hodgkin Lymphoma | Relapsed or Refractory Chronic Lymphocytic LeukemiaUnited Kingdom, Spain, France, Australia
-
Uppsala UniversityDalarna County Council, Sweden; Uppsala County Council, SwedenNot yet recruitingMyeloma Multiple
-
Cartesian TherapeuticsRecruiting
-
Poitiers University HospitalSanofi; Intergroupe Francophone du MyelomeActive, not recruitingMultiple Myeloma | Myeloma | Myeloma MultipleFrance
-
Chong Kun Dang PharmaceuticalUnknownMyeloma, MultipleKorea, Republic of
-
University of LeedsKaryopharm Therapeutics Inc; Myeloma UKWithdrawnMyeloma MultipleUnited Kingdom
-
M.D. Anderson Cancer CenterRecruitingAcute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Secondary Acute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome and other conditionsUnited States
-
Cristiana Costa Chase, DONot yet recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Arbeitsgemeinschaft medikamentoese TumortherapieMedical University of Vienna; Sanofi; Assign Data Management and Biostatistics... and other collaboratorsRecruitingNewly Diagnosed Multiple MyelomaAustria, Greece, Serbia
-
Multiple Myeloma Research ConsortiumEli Lilly and Company; GlaxoSmithKline; AbbVie; Takeda; Genentech, Inc.; Celgene Corporation and other collaboratorsRecruitingRelapsed Refractory Multiple MyelomaUnited States
-
University of LeedsCompletedRelapsed or Refractory Multiple MyelomaUnited Kingdom
-
Memorial Sloan Kettering Cancer CenterExelixisCompletedRelapsed or Refractory Multiple MyelomaUnited States
-
OncotherapeuticsNot yet recruitingMultiple Myeloma in Relapse | Multiple Myeloma, Refractory
-
Marcela V. Maus, M.D.,Ph.D.RecruitingMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States
-
University of WashingtonRecruitingRefractory Multiple Myeloma | Plasma Cell Leukemia | Recurrent Multiple MyelomaUnited States
-
Second Affiliated Hospital, School of Medicine,...Recruiting
-
University of Campania "Luigi Vanvitelli"RecruitingPregnancy Complications | Obstetric Labor Complications | Preterm Birth | Obstetric Labor, Premature | Pregnancy, High Risk | Cervix; PregnancyItaly
-
Centre hospitalier de l'Université de Montréal...Maisonneuve-Rosemont HospitalWithdrawnHigh-risk Corneal Transplantation | Corneal Blindess | Corneal Inflammation | Deep Anterior Lamellar Keratoplasty
-
Rush University Medical CenterHarvard Medical School (HMS and HSDM); National Institute of Mental Health... and other collaboratorsCompletedClinical High Risk for PsychosisUnited States
-
Yale UniversityTerminatedClinical High Risk for PsychosisUnited States